(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRINCETON RADIATION ONCOLOGY

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLED SEC. 8 (6-YR)Type: CombinedOffice: United States

Quick snapshot

PRINCETON RADIATION ONCOLOGY

ST13

US500000088275709

Class

44

Filing

88275709

Registration

5970745

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLED SEC. 8 (6-YR)

Case type

Application and registration

Recorded events

30

Latest update

08/07/2026

Trademark type

Combined

Nice classes

44

Filing date

01/24/2019

Registration date

01/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/07/2026

Last transaction

08/07/2026

Responsible office

United States Patent and Trademark Office

Status code

710

Official register

Principal Register

First use anywhere

01/01/2019

First use in commerce

01/01/2019

Drawing code

3

Owner type

16

Owner location

EAST BRUNSWICK, NJ, US

Examiner

GOODSAID, IRA

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design comprised of five flattened ovals that look like leaves in which the first leaf on the far left is light blue, the second leaf is blue, the third leaf is dark blue, the fourth leaf is light purple, and the fifth leaf is dark purple; followed by the wording "PRINCETON" in blue over "Radiation Oncology" in purple.

Holders and representatives

Holders

TITAN HEALTH PARTNERS, LLC DBA ASTERA CANCER CARE
Regional Cancer Care Associates LLC

Representatives

Brett R. Harris, Esq. Wilentz, Goldman & Spitzer, PA

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical servicesradiationoncologycancer treatment services and providing information about cancer and health care

Publications

History of USPTO decisions and trademark events.

30 publications found

C8..

CANCELLED SEC. 8 (6-YR)

08/07/2026

ES7S

TEAS SECTION 7 SURRENDER RECEIVED

07/27/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/24/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/24/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/24/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/24/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/24/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/28/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/13/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/13/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/13/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/13/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/13/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/02/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2019

PUBO

PUBLISHED FOR OPPOSITION

11/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2019

ALIE

ASSIGNED TO LIE

10/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/04/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/01/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/05/2019

GNRT

NON-FINAL ACTION E-MAILED

04/05/2019

CNRT

NON-FINAL ACTION WRITTEN

04/05/2019

DOCK

ASSIGNED TO EXAMINER

04/04/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/21/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/16/2019

NWAP

NEW APPLICATION ENTERED

01/28/2019

Continuous trademark protection

Get notified about every new filing that threatens PRINCETON RADIATION ONCOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.